ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO 2021 Update on Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Advanced NSCLC
By
ecancer
FEATURING
Christina Baik
By
ecancer
FEATURING
Christina Baik
Login to view comments.
Click here to Login
